Skip to main content
BAXTER INTERNATIONAL INC logo

BAXTER INTERNATIONAL INC — Investor Relations & Filings

Ticker · BAX ISIN · US0718131099 LEI · J5OIVXX3P24RJRW5CK77 US Manufacturing
Open in API
Filings indexed 2,456 across all filing types
Latest filing 2019-10-24 Regulatory Filings
Country US United States of America
Listing US BAX

About BAXTER INTERNATIONAL INC

https://www.baxter.com/

Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes an announcement of preliminary operating results, an internal investigation into accounting misstatements, an FDA warning letter update, and litigation information. It does not contain full financial statements or detailed financial analysis typical of an Annual Report (10-K) or Interim Report (IR). It is not a transcript, proxy, or remuneration report. The document is a regulatory announcement of significant events and updates, fitting the category of Regulatory Filings (RNS). The document length (7372 characters) and content confirm it is not merely a report publication announcement but a substantive regulatory filing.
2019-10-24 English
PRIMARY DOCUMENT
Director's Dealing
2019-10-16 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement related to a pension plan annuity purchase, including financial impact details and transaction terms. It is not a full annual or quarterly report, nor is it an earnings release or management discussion. It is a regulatory announcement of a significant transaction and related financial impact, typical of an 8-K filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2019-10-09 English
PRIMARY DOCUMENT
Director's Dealing
2019-09-17 English
PRIMARY DOCUMENT
Director's Dealing
2019-09-06 English
PRIMARY DOCUMENT
Director's Dealing
2019-09-04 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.